A Study of CD19 Targeted CAR T Cell Therapy in Patients With Severe, Refractory Systemic Lupus Erythematosus (SLE)

Conditions: Systemic Lupus Erythematosus Interventions: Biological: Obecabtagene autoleucel (obe-cel) Sponsors: Autolus Limited Recruiting

Source: ClinicalTrials.gov - March 27, 2024 Category: Research Source Type: clinical trials